insights_auto
Outlook: 84.0% bullish·0.0% bearish
Go to analysischevron_right
VSTM:NASDAQ
Verastem Inc
$8.54
arrow_downward
-1.27%(-0.11) 1D
Oct 19, 11:11:27 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VSTM...
Open
$8.58
High
$9.17
Low
$8.51
Mkt. cap
1.04B
Avg. vol.
4.21M
Volume
1.00M
52-wk high
$10.82
52-wk low
$3.43
EPS
-$2.46
Beta
0.39
Shares outstanding
121.50M
No. of employees
102
Open
$8.58
High
$9.17
Low
$8.51
Mkt. cap
1.04B
Avg. vol.
4.21M
Volume
1.00M
52-wk high
$10.82
52-wk low
$3.43
EPS
-$2.46
Beta
0.39
Shares outstanding
121.50M
No. of employees
102
News stories
From web sources and news partners
ad-hoc-news.de
·
1 day ago
Jefferies raises target for Verastem Oncology stock from USD 11.00 to USD 13.00
Simply Wall Street
·
1 day ago
Verastem (VSTM) Could Be 50% Undervalued Following VS 7375 Data And Equity Raise
Profile
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia
About Verastem Inc
CEOBrian Stuglik
Employees102
Founded2010
HeadquartersNeedham, Massachusetts, United States
SectorBiotechnology
Websiteverastem.com